Survival after relapse by karyotype at first relapse. (A) Patients without a karyotype change (n = 11) had a median survival after relapse of 9.0 months, whereas those with a change (n = 23) had a median of 3.6 months (P = .07). (B) Survival after relapse by cytogenetic risk group.